Sensory neuronal P2RX4 receptors controls BDNF signaling in inflammatory pain

Sarah Lalisse (1) , Jennifer Hua (1) , Manon Lenoir (1) , Nathalie Linck (1) , François Rassendren (1) , Lauriane Ulmann (1)

1 IGF - Institut de Génomique Fonctionnelle

Chronic inflammatory and neuropathic pains are major public health concerns. Potential therapeutic targets include the ATP-gated purinergic receptors (P2RX) that contribute to these pathological types of pain in several different cell types. The purinergic receptors P2RX2 and P2RX3 are expressed by a specific subset of dorsal root ganglion neurons and directly shape pain processing by primary afferents. In contrast the P2RX4 and P2RX7 are mostly expressed in myeloid cells, where activation of these receptors triggers the release of various pro-inflammatory molecules. Here, we demonstrate that P2RX4 also controls calcium influx in mouse dorsal root ganglion neurons. P2RX4 is up-regulated in pain-processing neurons during long lasting peripheral inflammation and it co-localizes with Brain-Derived Neurotrophic Factor (BDNF). In the dorsal horn of the spinal cord, BDNF-dependent signaling pathways, phosphorylation of Erk1/2 and of the GluN1 subunit as well as the down regulation of the co-transporter KCC2, which are triggered by peripheral inflammation are impaired in P2RX4-deficient mice. Our results suggest that P2RX4, expressed by sensory neurons, controls neuronal BDNF release that contributes to hyper-excitability during chronic inflammatory pain and establish P2RX4 in sensory neurons as a new potential therapeutic target to treat hyperexcitability during chronic inflammatory pain.

Domaines: Neurobiologie

Sarah Lalisse, Jennifer Hua, Manon Lenoir, Nathalie Linck, François Rassendren, et al.. Sensory neuronal P2RX4 receptors controls BDNF signaling in inflammatory pain. Scientific Reports, 2018, 8, pp.964. ⟨10.1038/s41598-018-19301-5⟩. ⟨hal-02395199⟩